2017 Glaucoma Surgical Device Report: A Global Market Analysis for 2016 to 2022
Our report on the glaucoma surgical device market is in its eleventh edition. It is a leading industry source for accurate and relevant information on all aspects of the glaucoma surgical device market. We cover prevalence and forecasts for glaucoma worldwide, and we discuss the ophthalmologists who treat glaucoma. We examine the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes. We forecast product demand in units and dollars, and we analyze market shares by product category. We also discuss key strategic issues.
What's New? In the 2017 report, we focus on all types of glaucoma surgery and show how minimally invasive glaucoma surgery (MIGS) stents will dramatically change glaucoma care, leading to patients being treated at an earlier stage in the disease process. We expect the size of the glaucoma surgical device market to more than triple over the next five years, driven largely by the impact of MIGS stents. The list of companies participating in the MIGS space continues to grow and includes Glaukos, Allergan, Alcon, Ivantis, and Santen, and we look at the challenges and opportunities each will face in the coming years.
Market Scope’s 2017 Glaucoma Surgical Device Report: A Global Market Analysis for 2016 to 2022 provides in-depth coverage of current and future surgical devices for treating glaucoma.
Four Categories Are Analyzed In This Report:
Conventional Glaucoma Surgery (CGS) Devices, Advanced Technology Glaucoma Surgery (ATGS) Devices, Selective Trabeculoplasty (SLT) Lasers, and Disposables/Instruments
Each Market Segment Includes:
An Analysis of Market Competitors and Five‐Year Forecasts for Market Performance
Also Included in This Report:
• Background on Glaucoma and its Forms
• The Global Glaucoma Populations
• Glaucoma Care Providers
• Diagnosing Glaucoma
• Treating Glaucoma
• Investigational Devices in the Pipeline
• 34 Company Proﬁles
• 78 Color Tables and 55 Color Figures
The data included in our reports is based on surveys of ophthalmologists, reviews of clinical data, interviews with company executives, and analysis of company financial data.
This edition of our 2017 Glaucoma Surgical Device Report: A Global Market Analysis for 2016 to 2022 was released in August 2017. The report is printed in color and spiral bound for easy reading. Two licensing types are available for this report. The price of the report is $5,750 for a SINGLE USER LICENSE (an electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively). The price of the ENTERPRISE LICENSE is $8,625 (includes a printable PDF and supplemental Excel file with all the tables and figures in the report).
VIEW THE TABLE OF CONTENTS FOR THIS REPORT
*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.
Market Scope’s industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective ophthalmic experience and each data point is driven by a combination of sources, including the following:
• Our proprietary global disease population and demographic models
• Twenty years and counting of ophthalmologist survey data
• Analysis of company published financial reports
• Focused coverage of ophthalmic scientific research, business news and other activities
• Attendance and participation in major, worldwide ophthalmic meetings
• Interviews and long-standing relationships with company executives and practicing ophthalmologists